- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast 2024 Half Year Financial Results Webcast
Ann: Mesoblast 2024 Half Year Financial Results Webcast, page-49
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.06 |
Change
0.048(4.70%) |
Mkt cap ! $1.210B |
Open | High | Low | Value | Volume |
$1.01 | $1.07 | $1.00 | $3.025M | 2.906M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
56 | 102547 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.06 | 19861 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
57 | 76266 | 1.055 |
16 | 71248 | 1.050 |
13 | 86200 | 1.045 |
10 | 148487 | 1.040 |
4 | 242531 | 1.035 |
Price($) | Vol. | No. |
---|---|---|
1.060 | 50052 | 14 |
1.065 | 122122 | 13 |
1.070 | 109181 | 14 |
1.075 | 1056065 | 7 |
1.080 | 295571 | 9 |
Last trade - 15.56pm 24/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online